BioMarin Pharmaceutical Comprehensive Income 2010-2024 | BMRN

BioMarin Pharmaceutical comprehensive income for the quarter ending December 31, 2024 was $0.062B, a 314.16% decline year-over-year.

  • BioMarin Pharmaceutical comprehensive income for 2024 was $0.062B, a 314.16% decline from 2023.
  • BioMarin Pharmaceutical comprehensive income for 2023 was $-0.029B, a 644.45% increase from 2022.
  • BioMarin Pharmaceutical comprehensive income for 2022 was $-0.004B, a 126.79% decline from 2021.

BioMarin Pharmaceutical Comprehensive Income 2010-2024 | BMRN

  • BioMarin Pharmaceutical comprehensive income for 2024 was $0.062B, a 314.16% decline from 2023.
  • BioMarin Pharmaceutical comprehensive income for 2023 was $-0.029B, a 644.45% increase from 2022.
  • BioMarin Pharmaceutical comprehensive income for 2022 was $-0.004B, a 126.79% decline from 2021.